Basil Drugs Private Limited
About Basil Drugs Private Limited
Data last updated:
Basil Drugs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 April 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2001PTC014624. Its GSTIN is 23AACCB2576R1ZB (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Basil Drugs Limited. It is led by directors including Rajesh Kumar Singh (Managing Director) and Tara Kushwaha (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N – 60 Anoop Nagar, Indore, Madhya Pradesh, India – 452011.
As per the financials filed for FY 2016, the company reported a revenue of ₹1.16 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.09 Lakh (net margin 0.9%) and EBITDA of ₹4.49 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹6.83 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressN – 60 Anoop Nagar, Indore, Madhya Pradesh, India – 452011
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Basil Drugs Private Limited FY 2025 filings available
Basil Drugs Private Limited reported revenue of ₹1.16 Cr (up 5% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR) of Basil Drugs Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 5% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Basil Drugs Private Limited
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | ₹1.16 Cr | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹4.49 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹1.09 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Basil Drugs Private Limited
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.9% | •••• |
| Net Profit Margin | 0.9% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Basil Drugs are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Basil Drugs Private Limited
Basil Drugs Private Limited is audited by A GATTANI & ASSOCIATES for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A GATTANI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Basil Drugs Private Limited
Basil Drugs has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Singh | Managing Director | 16 Apr 2001 | 25 Years 5 Months | Current |
| Tara Kushwaha | Whole-Time Director | 16 Apr 2001 | 25 Years 5 Months | Current |
| Mohammad Shakil Sheikh | Whole-Time Director | 30 Sep 2007 | 19 Years 0 Months | Current |
Ownership and Shareholding of Basil Drugs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Basil Drugs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Aug 2018 | Others | ₹2.58 Lakh | Open |
| 18 Dec 2015 | Icici Bank Limited | ₹2.25 Lakh | Open |
| 17 Oct 2001 | State Bank of Indore | ₹2 Lakh | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Basil Drugs Private Limited
Employment history and EPFO contributions of people linked to Basil Drugs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Basil Drugs Private Limited
Basil Drugs has one previous CIN (Corporate Identification Number): U24232MP2001PLC014624. The current CIN is U24232MP2001PTC014624, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232MP2001PTC014624 | Current |
| U24232MP2001PLC014624 | Previous |
Recent Activity on Basil Drugs Private Limited
Basil Drugs Private Limited has 7 board changes on record since 2001: 3 appointments and 4 cessations. The latest: Mohammad Shakil Sheikh ceased to be Director on 01 Oct 2013.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Basil Drugs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Basil Drugs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Basil Drugs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Basil Drugs Private Limited
Basil Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCB2576R1ZB | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Basil Drugs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Basil Drugs Private Limited
Basil Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 April 2001 (25+ years old) and is registered under CIN U24232MP2001PTC014624.
Basil Drugs reported revenue of ₹1.16 Cr for FY 2016 (up 5% YoY).
Basil Drugs has 3 current directors:
- Rajesh Kumar Singh - Managing Director
- Tara Kushwaha - Whole-Time Director
- Mohammad Shakil Sheikh - Whole-Time Director
Basil Drugs reported a net profit of ₹1.09 Lakh (net margin 0.9%) and EBITDA of ₹4.49 Lakh (EBITDA margin 3.9%) for FY 2016, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Basil Drugs is 9% over three years and 13% over five years. In the latest year (FY 2016) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Basil Drugs is 23AACCB2576R1ZB, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Basil Drugs is U24232MP2001PTC014624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Basil Drugs was incorporated on 16 April 2001, making it 25+ years old. It is registered with the Registrar of Companies, Gwalior.
Mohammad Shakil Sheikh ceased to be Director on 01 Oct 2013. Rajesh Kumar Singh ceased to be Director on 01 Oct 2013. Tara Kushwaha ceased to be Director on 01 Oct 2013. Basil Drugs has 7 board changes on record in total.
The registered office of Basil Drugs is at N – 60 Anoop Nagar, Indore, Madhya Pradesh, India – 452011.